Le Lézard
Classified in: Health, Sports and recreation
Subjects: NPT, CHI, FVT

Communities Across the U.S. to Join Olympians at Legendary Deer Valley Resort to End Blood Cancer


In its 6th year The Leukemia & Lymphoma Society's Shred For Red philanthropic fundraising event culminates with an exciting day skiing the slopes

RYE BROOK, N.Y., Nov. 6, 2023 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) is kicking off the ski season with huge goal in mind: to end blood cancer. Communities nationwide will be joined by past Olympians including Nordic skier Bryan Fletcher at LLS's "Shred For Red" event at the legendary Deer Valley Resort in Park City, UT, often referred to as "The Greatest Snow on Earth".

Happening on December 2, Shred For Red is a fun and family-friendly event where dedicated volunteers raise funds to end blood cancer, while skiing some of the best slopes in the world and enjoying lively winter activities.

"Shred For Red is one of LLS's newest national philanthropic campaigns and we're thrilled to have the support from past Olympians and relentless volunteers who are helping us get closer to our goal of a world without blood cancer," said Coker Powell, LLS Chief Development Officer.

Shred For Red's National Honored Hero, Reilly of Holladay, UT, was diagnosed with B-cell acute lymphocytic leukemia at the young age of five years old. Today, he is almost one-and-a-half years through his two-and-a-half-year treatment plan and has already endured grueling side effects including nausea, low counts requiring transfusions, and leg and back pain.

"Despite all he's going through, Reilly continues to be a spunky seven-year-old and even graduated from Kindergarten (after attending on Zoom) and started first grade in person this year," said his mom, Erin.

A ski fan himself, Reilly will be in attendance sporting a special ski bib with the Olympians' signatures, who he calls his "heroes" but as Bryan Fletcher noted, "Reilly is the true hero and serves as an inspiration to all of us."

Through The Dare to Dream Project, LLS is executing its bold vision for pediatric blood cancer patients ? to not only survive their cancer but thrive in their lives after treatment. While many children survive leukemia, the most common type of pediatric cancer, the treatments are harsh and outdated. Over the course of this multi-year initiative, LLS is increasing investments in pediatric cancer research, including the launch of PedAL, the first-of-its kind master clinical trial for acute leukemia patients, expanding education and support services for patients and families, and driving advocacy and policy efforts to break down barriers to critical care and prioritize blood cancer research for children.

Shred for Red is open to skiers of all abilities. To be eligible to participate, adults must raise a minimum of $500 ($300 for children under 12). Participants will receive and have access to the following:

Since its founding in 1949, LLS has invested more than $1.6 billion in cutting-edge blood cancer research worldwide, and its support has been instrumental in the development of nearly every breakthrough in blood cancer treatment. With a more than 70-year track record, LLS has supported virtually every advancement in blood cancer treatment.

To learn more, visit www.lls.org/shredforred

Blood cancer patients and their families can contact the LLS Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m., ET.

About The Leukemia & Lymphoma Society   

The Leukemia & Lymphoma Society® (LLS) is the global leader in the fight against blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease, and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.   

Founded in 1949 and headquartered in Rye Brook, NY, LLS has regions throughout the United States and Canada. To learn more, visit?www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.   

LLS is the only organization featured in the nonprofit category on both Fast Company's 2022 Brands That Matter list and the 2023 Best Workplaces for Innovators list. LLS stands out among brands around the world for its relevancy, cultural impact, ingenuity, and mission impact.   

For additional information, visit lls.org/lls-newsnetwork. Follow us on?Facebook, Twitter, Instagram, and LinkedIn

For media inquiries only, please contact [email protected].

SOURCE The Leukemia & Lymphoma Society (LLS)


These press releases may also interest you

at 11:56
Inc. Magazine revealed that GetMed Staffing is No. 23 on its fourth annual Inc. Regionals: Midwest list, the most prestigious ranking of the fastest-growing Midwest private...

at 07:00
With Super Tuesday around the corner and the next presidential election looming, many of us are feeling our anxiety rise. If you've found yourself tossing and turning at night, unable to relax the tension in your shoulders, or even having stomach...

at 06:00
Scarborough Health Network (SHN) Foundation is thrilled to announce a generous donation of $1 million from the Honey & Barry Sherman Legacy Foundation to support exceptional healthcare for Scarborough. $1 million to Scarborough Health Network from...

1 mar 2024
The deadline for the Registered Nurses' Association of Ontario's (RNAO) annual Media Awards competition has been extended until March 8. The competition honours outstanding nursing and health-care journalism in a variety of categories: community...

1 mar 2024
On Thursday, February 29, an Allegheny County jury awarded a 62-year-old man from Mars, PA, $1.4 million in damages for negligence resulting from a fall that caused permanent injury to his dominant arm. The incident occurred when the man was admitted...

1 mar 2024
The "Asia-Pacific Artificial Intelligence/ Machine Learning Medical Device Market: Analysis and Forecast, 2022-2032" report has been added to  ResearchAndMarkets.com's offering. The Asia-Pacific artificial intelligence/machine learning medical...



News published on and distributed by: